Global X Video Games & Esports ETF (HERO)
Price:
30.20 USD
( - -0.61 USD)
Your position:
0 USD
ACTION PANEL
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Strategy Shares Nasdaq 7 Handl Index ETF
VALUE SCORE:
9
2nd position
Angel Oak Ultrashort Income ETF
VALUE SCORE:
12
The best
Invesco Variable Rate Investment Grade ETF
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from increased consumption related to video games and esports. It is non-diversified.
NEWS

A HERO RISES IN THE NEW TRAILER FOR EXODUS
businesswire.com
2025-12-11 21:00:00RENTON, Wash. & AUSTIN, Texas--(BUSINESS WIRE)--Wizards of the Coast and Archetype Entertainment today debuted the new trailer for EXODUS™ at The Game Awards. The trailer provides fans with a more in-depth look at Jun Aslan, a hero on an epic journey across the universe to save a world on the brink of collapse. Jun comes from humble beginnings, but carries the legacy of a revered Traveler dynasty. Hidden beneath his unassuming origins lies a genetic heritage that grants Jun extraordinary powers.

Flow Traders U.S. LLC Sells 21,186 Shares of Global X Video Games & Esports ETF $HERO
defenseworld.net
2025-12-11 04:07:29Flow Traders U.S. LLC trimmed its position in Global X Video Games and Esports ETF (NASDAQ: HERO) by 53.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,456 shares of the company's stock after selling 21,186 shares during the

Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
globenewswire.com
2025-12-10 16:05:00Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readout Clinical trial sites in Canada and the United Kingdom have received regulatory clearance to enroll All patients who have completed HERO trial to date have successfully enrolled and remain in the Open Label Extension trial SAN DIEGO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that the first patient has been dosed in Australia in its Phase 3 HERO pivotal clinical trial assessing ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi syndrome (PWS). Additionally, regulatory clearance for enrollment by clinical trial sites in Canada and the United Kingdom has also been received.

HERO: Gaming Industry Has A Favorable Momentum
seekingalpha.com
2025-12-08 05:50:22HERO ETF offers investors an opportunity to benefit from companies in the video game industry. The prospects of the industry are improving thanks to the structural changes and the in-game monetization approach. I am rating HERO with a Buy rating, as the market is expected to see a favorable tailwind from cloud gaming, artificial intelligence, and AR/VR technologies.

SSCP-OWNED APPLEBEE'S IN TEXAS, CALIFORNIA AND VIRGINIA ENCOURAGE GUESTS TO 'BUY A HERO A BUD' IN ANTICIPATION OF VETERANS DAY
prnewswire.com
2025-10-09 10:12:00Applebee's franchise partner expects to sell 10,000 Bud Light beers for America's veterans; all residual funds to benefit nonprofit, Folds of Honor DALLAS , Oct. 9, 2025 /PRNewswire/ -- SSCP, an Applebee's franchisee operating in Texas, California, and Virginia, announced today that it will once again host its annual "Buy A Hero a Bud" program in partnership with Anheuser-Busch, in tandem with Applebee's national Veterans Day promotion on November 11. Beginning today and through November 10, guests at SSCP-owned Applebee's can "Buy A Hero A Bud" in advance of Veterans Day for their local military heroes.

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
globenewswire.com
2025-10-08 08:00:00SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announces alignment with the U.S. Food and Drug Administration (FDA) on a protocol amendment to the company's Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS). The protocol amendment changes the minimum age of eligibility to participate in the trial from 13 to 10 years old.

BrandPilot AI to Present AI-Powered Ad Waste Solutions at BrightonSEO & HERO Conf San Diego
newsfilecorp.com
2025-09-22 12:46:00Company Highlights Industry-Leading Approach to Search and Paid Media Optimization Toronto, Ontario--(Newsfile Corp. - September 22, 2025) - BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) ("BrandPilot" or the "Company"), a leading innovator in AI-powered marketing and advertising technology, announced today that it will present at BrightonSEO & HERO Conference, taking place September 23-24, 2025, at the Manchester Grand Hyatt in San Diego, CA. BrandPilot's Chief Revenue Officer, John Beresford, will deliver a session entitled "Eliminating Hidden Waste in Paid Search: AI-Driven Strategies for Enterprise ROI.

Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror
etftrends.com
2025-09-10 13:23:45It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this year's thematic ETF rearview mirror.

HERO: Falling Short Of Its Core Objectives
seekingalpha.com
2025-09-06 00:29:04HERO is a hold due to its inability to capture high-growth, innovative, and paradigm-shifting gaming companies, lagging behind peers like ESPO. The ETF's top holdings—Electronic Arts, Nintendo, and Konami—demonstrate weak growth, minimal innovation, and a lack of transformative breakthroughs. HERO's performance, high fees, and low dividend yield make it less attractive compared to peer gaming ETFs, especially ESPO.

Why HERO, TTWO, AND RBLX are Must-Buy Stocks Today
247wallst.com
2025-08-26 11:06:17The company recently posted 21% year-over-year revenue growth to $1.1 billion.

Disruptive Theme of the Week: Video Gaming
etftrends.com
2025-07-01 13:28:46Some of the top-performing themes of this year totally make sense given current geopolitical and macro headwinds. Those include gold, defense, uranium and nuclear.

Best-Performing Sector ETFs of the Second Quarter
zacks.com
2025-06-26 11:00:13URA, CRPT and ARKW and others soar in the second quarter of 2025 as tech, crypto, and uranium sectors lead a stunning market rebound from April's slump.

S&P 500 Makes the Fastest Recovery Since 1982: 5 Best ETFs
zacks.com
2025-05-14 11:10:45The S&P 500 wipes out all its losses and returns to positive territory. We highlight the five best ETFs of this year.

HERO: Who Knew Video Games Were So Profitable
seekingalpha.com
2025-05-12 23:37:50Global X Video Games & Esports ETF shows strong growth potential, driven by robust performance from key holdings like Konami and Roblox, despite a modest AUM. HERO's recent 20% price increase outperformed the S&P 500, highlighting its resilience and growth prospects in the expanding $205 billion video game market. The ETF's diversified portfolio, with significant allocations to Japanese, U.S., and Chinese gaming companies, supports its impressive performance and future growth potential.

Video Game ETFs Outperform in February: Here's Why
zacks.com
2025-02-28 12:00:28Video game stocks outperform the broader market on the highly anticipated launch of game releases.

Amplify Revamps Video Game Tech ETF With New Index
etftrends.com
2025-01-28 12:21:13Amplify has made a notable update to its video game tech ETF. The Amplify Video Game Tech ETF (GAMR) has changed its underlying index and is now tracking the VettaFi Video Game Leaders Index (VGAME), effective January 28.
No data to display

A HERO RISES IN THE NEW TRAILER FOR EXODUS
businesswire.com
2025-12-11 21:00:00RENTON, Wash. & AUSTIN, Texas--(BUSINESS WIRE)--Wizards of the Coast and Archetype Entertainment today debuted the new trailer for EXODUS™ at The Game Awards. The trailer provides fans with a more in-depth look at Jun Aslan, a hero on an epic journey across the universe to save a world on the brink of collapse. Jun comes from humble beginnings, but carries the legacy of a revered Traveler dynasty. Hidden beneath his unassuming origins lies a genetic heritage that grants Jun extraordinary powers.

Flow Traders U.S. LLC Sells 21,186 Shares of Global X Video Games & Esports ETF $HERO
defenseworld.net
2025-12-11 04:07:29Flow Traders U.S. LLC trimmed its position in Global X Video Games and Esports ETF (NASDAQ: HERO) by 53.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,456 shares of the company's stock after selling 21,186 shares during the

Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
globenewswire.com
2025-12-10 16:05:00Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readout Clinical trial sites in Canada and the United Kingdom have received regulatory clearance to enroll All patients who have completed HERO trial to date have successfully enrolled and remain in the Open Label Extension trial SAN DIEGO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that the first patient has been dosed in Australia in its Phase 3 HERO pivotal clinical trial assessing ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi syndrome (PWS). Additionally, regulatory clearance for enrollment by clinical trial sites in Canada and the United Kingdom has also been received.

HERO: Gaming Industry Has A Favorable Momentum
seekingalpha.com
2025-12-08 05:50:22HERO ETF offers investors an opportunity to benefit from companies in the video game industry. The prospects of the industry are improving thanks to the structural changes and the in-game monetization approach. I am rating HERO with a Buy rating, as the market is expected to see a favorable tailwind from cloud gaming, artificial intelligence, and AR/VR technologies.

SSCP-OWNED APPLEBEE'S IN TEXAS, CALIFORNIA AND VIRGINIA ENCOURAGE GUESTS TO 'BUY A HERO A BUD' IN ANTICIPATION OF VETERANS DAY
prnewswire.com
2025-10-09 10:12:00Applebee's franchise partner expects to sell 10,000 Bud Light beers for America's veterans; all residual funds to benefit nonprofit, Folds of Honor DALLAS , Oct. 9, 2025 /PRNewswire/ -- SSCP, an Applebee's franchisee operating in Texas, California, and Virginia, announced today that it will once again host its annual "Buy A Hero a Bud" program in partnership with Anheuser-Busch, in tandem with Applebee's national Veterans Day promotion on November 11. Beginning today and through November 10, guests at SSCP-owned Applebee's can "Buy A Hero A Bud" in advance of Veterans Day for their local military heroes.

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
globenewswire.com
2025-10-08 08:00:00SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announces alignment with the U.S. Food and Drug Administration (FDA) on a protocol amendment to the company's Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS). The protocol amendment changes the minimum age of eligibility to participate in the trial from 13 to 10 years old.

BrandPilot AI to Present AI-Powered Ad Waste Solutions at BrightonSEO & HERO Conf San Diego
newsfilecorp.com
2025-09-22 12:46:00Company Highlights Industry-Leading Approach to Search and Paid Media Optimization Toronto, Ontario--(Newsfile Corp. - September 22, 2025) - BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) ("BrandPilot" or the "Company"), a leading innovator in AI-powered marketing and advertising technology, announced today that it will present at BrightonSEO & HERO Conference, taking place September 23-24, 2025, at the Manchester Grand Hyatt in San Diego, CA. BrandPilot's Chief Revenue Officer, John Beresford, will deliver a session entitled "Eliminating Hidden Waste in Paid Search: AI-Driven Strategies for Enterprise ROI.

Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror
etftrends.com
2025-09-10 13:23:45It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this year's thematic ETF rearview mirror.

HERO: Falling Short Of Its Core Objectives
seekingalpha.com
2025-09-06 00:29:04HERO is a hold due to its inability to capture high-growth, innovative, and paradigm-shifting gaming companies, lagging behind peers like ESPO. The ETF's top holdings—Electronic Arts, Nintendo, and Konami—demonstrate weak growth, minimal innovation, and a lack of transformative breakthroughs. HERO's performance, high fees, and low dividend yield make it less attractive compared to peer gaming ETFs, especially ESPO.

Why HERO, TTWO, AND RBLX are Must-Buy Stocks Today
247wallst.com
2025-08-26 11:06:17The company recently posted 21% year-over-year revenue growth to $1.1 billion.

Disruptive Theme of the Week: Video Gaming
etftrends.com
2025-07-01 13:28:46Some of the top-performing themes of this year totally make sense given current geopolitical and macro headwinds. Those include gold, defense, uranium and nuclear.

Best-Performing Sector ETFs of the Second Quarter
zacks.com
2025-06-26 11:00:13URA, CRPT and ARKW and others soar in the second quarter of 2025 as tech, crypto, and uranium sectors lead a stunning market rebound from April's slump.

S&P 500 Makes the Fastest Recovery Since 1982: 5 Best ETFs
zacks.com
2025-05-14 11:10:45The S&P 500 wipes out all its losses and returns to positive territory. We highlight the five best ETFs of this year.

HERO: Who Knew Video Games Were So Profitable
seekingalpha.com
2025-05-12 23:37:50Global X Video Games & Esports ETF shows strong growth potential, driven by robust performance from key holdings like Konami and Roblox, despite a modest AUM. HERO's recent 20% price increase outperformed the S&P 500, highlighting its resilience and growth prospects in the expanding $205 billion video game market. The ETF's diversified portfolio, with significant allocations to Japanese, U.S., and Chinese gaming companies, supports its impressive performance and future growth potential.

Video Game ETFs Outperform in February: Here's Why
zacks.com
2025-02-28 12:00:28Video game stocks outperform the broader market on the highly anticipated launch of game releases.

Amplify Revamps Video Game Tech ETF With New Index
etftrends.com
2025-01-28 12:21:13Amplify has made a notable update to its video game tech ETF. The Amplify Video Game Tech ETF (GAMR) has changed its underlying index and is now tracking the VettaFi Video Game Leaders Index (VGAME), effective January 28.










